AtriCure, Inc.
ATRC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.4% | 10.1% | -0.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.5% | 74.5% | 74.9% | 74.5% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 5.9% | 0.5% | -4.8% | -7.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.2% | -4.5% | -5.5% | -12.5% |
| EPS Diluted | -0.01 | -0.13 | -0.14 | -0.33 |
| % Growth | 92.3% | 7.1% | 57.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |